Both in Pharmaceuticals
Eli Lilly & vs Merck & Co.
Over the past year LLY returned +63.1% and MRK returned +89.2%; their daily moves had a correlation of 0.44.
LLY +63.1% MRK +89.2%Growth of $1, one year, split-adjusted
| Metric | LLY | MRK |
|---|---|---|
| Price | $1,184.78 | $148.69 |
| Market cap | $1.06T | $366.84B |
| Today | +0.11% | −0.06% |
| 1 month | +0.7% | −0.6% |
| 6 months | +34.9% | +24.3% |
| Year to date | +10.2% | +41.3% |
| 1 year | +65.8% | +91.6% |
| Revenue growth (YoY) | +47.7% | +5.1% |
| Gross margin | 85.8% | 73.5% |
| Net margin | 30.9% | −8.0% |
| P/E (TTM) | 39.5× | 115.6× |
| Price / sales | 13.3× | 5.5× |
| Net cash | -$45.96B | -$46.77B |
| Dividend yield | 0.58% | 2.29% |
| Volatility (60d) | 29.7% | 33.5% |
| Short % of float | 0.9% | 1.4% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).